Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer
Authors
Keywords
-
Journal
Clinical & Developmental Immunology
Volume 2010, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2010-09-16
DOI
10.1155/2010/891505
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tissue Microarray : A rapidly evolving diagnostic and research tool
- (2009) NazarM.T. Jawhar ANNALS OF SAUDI MEDICINE
- Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/- Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN- 2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
- (2009) J. M. Kirkwood et al. CLINICAL CANCER RESEARCH
- New therapeutic agents in ovarian cancer
- (2009) Fiona Collinson et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer
- (2009) Ninke Leffers et al. GYNECOLOGIC ONCOLOGY
- Cancer/testis antigen CT45: Analysis of mRNA and protein expression in human cancer
- (2009) Yao-Tseng Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells
- (2009) Christine Sers et al. INTERNATIONAL JOURNAL OF CANCER
- Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial
- (2009) Ninke Leffers et al. INTERNATIONAL JOURNAL OF CANCER
- Multi-peptide vaccines vialed as peptide mixtures can be stable reagents for use in peptide-based immune therapies
- (2009) Kimberly A. Chianese-Bullock et al. VACCINE
- DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance
- (2008) C. Chaise et al. BLOOD
- The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
- (2008) P de Graeff et al. BRITISH JOURNAL OF CANCER
- Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion
- (2008) Maria V. Barbolina et al. CANCER
- Cetuximab: Preclinical Evaluation of a Monoclonal Antibody Targeting EGFR for Radioimmunodiagnostic and Radioimmunotherapeutic Applications
- (2008) Diane E. Milenic et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1
- (2008) Junko Matsuzaki et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated with Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer
- (2008) A. Woloszynska-Read et al. CLINICAL CANCER RESEARCH
- Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity
- (2008) G. G. Kenter et al. CLINICAL CANCER RESEARCH
- Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission
- (2008) C. S.M. Diefenbach et al. CLINICAL CANCER RESEARCH
- WT1 peptide vaccine for the treatment of cancer
- (2008) Yoshihiro Oka et al. CURRENT OPINION IN IMMUNOLOGY
- Mode-of-Action, Efficacy, and Safety of a Homologous Multi-Epitope Vaccine in a Murine Model for Adjuvant Treatment of Renal Cell Carcinoma
- (2008) Christian Doehn et al. EUROPEAN UROLOGY
- Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation
- (2008) Ninke Leffers et al. GYNECOLOGIC ONCOLOGY
- Antigen-specific immunotherapy of cervical and ovarian cancer
- (2008) Chien-Fu Hung et al. IMMUNOLOGICAL REVIEWS
- Next Generation of Immunotherapy for Melanoma
- (2008) John M. Kirkwood et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer
- (2008) Tetsuhiro Tsuruma et al. Journal of Translational Medicine
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
- (2008) Naomi N. Hunder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-Infiltrating T Cells Correlate with NY-ESO-1-Specific Autoantibodies in Ovarian Cancer
- (2008) Katy Milne et al. PLoS One
- Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2
- (2008) Inge Marie Svane et al. VACCINE
- WT1-specific T cell receptor gene therapy: Improving TCR function in transduced T cells
- (2007) Hans J. Stauss et al. BLOOD CELLS MOLECULES AND DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More